Amgen (AMGN) Tops Q1 EPS by 30c, Raises FY Guidance
Tweet
Share
E-mail
Get Alerts AMGN Hot Sheet
Price: $344.72 --0%
Revenue Growth %: +2.7%
Financial Fact:
Total operating expenses: 3.28B
Today's EPS Names:
JFIN, KEQU, LASE, More
Revenue Growth %: +2.7%
Financial Fact:
Total operating expenses: 3.28B
Today's EPS Names:
JFIN, KEQU, LASE, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q1 EPS of $2.90, $0.30 better than the analyst estimate of $2.60. Revenue for the quarter came in at $5.53 billion versus the consensus estimate of $5.32 billion.
GUIDANCE:
Amgen sees FY2016 EPS of $10.85-$11.20, versus prior guidance of $10.60-$11.00 and the consensus of $10.82.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AeroVironment restates quarterly financials, citing $89M goodwill error
- OneMain (OMF) Reiterated at Market Outperform by Citizens on Updated Estimates
- Primoris cuts 2026 outlook on renewables cost overruns, COO exits
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
